{"id":533707,"date":"2021-09-02T07:34:22","date_gmt":"2021-09-02T11:34:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/"},"modified":"2021-09-02T07:34:22","modified_gmt":"2021-09-02T11:34:22","slug":"medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/","title":{"rendered":"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue"},"content":{"rendered":"<div class=\"mw_release\">\n<p>In recent pre- clinical studies, Polyrizon products showed strong potential by preventing coronavirus and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells&#8217; death.<\/p>\n<p align=\"justify\">\n        <strong>OMER, Israel, Sept.  02, 2021  (GLOBE NEWSWIRE) &#8212; <\/strong> Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, has submitted an additional patent application to the United States Patent and Trademark Office for its innovative technology.<\/p>\n<p align=\"justify\">The invention generally pertains to the field of hydrogels that are capable to capture and contain biological assaults intrusion through the upper airways and eye cavities. Furthermore, the invention details a novel modality for a delivery system for drugs through the nasal mucosa that could get more drug into the body, and resides longer in the nasal cavity.<\/p>\n<p align=\"justify\">Recent pre-clinical data by Polyrizon, showed that its product candidate has the potential to reduce the risk of an infection with human coronavirus and may also prevent COVID-19 as well as Influenza Virus H1N1 and may potentially also treat additional Cold viruses.<\/p>\n<p align=\"justify\">Polyrizon\u2019s product candidate protects the nasal cavity and the respiratory tract, prevents the virus from colonizing in the upper respiratory, potentially decreases the viral load and facilitates the immune system to control the virus more effectively.<\/p>\n<p align=\"justify\">This pre-clinical data highlights the Capture and Contain (C&amp;C\u2122) impact of Polyrizon\u2019s product line that can be extended against Coronavirus, Influenza and Cold viruses and a variety of different respiratory viruses.<\/p>\n<p>\n        <b>About Medigus<\/b>\n      <\/p>\n<p align=\"justify\">Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technologies company that is focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce, and electric vehicle markets. Medigus&#8217; affiliations in the medical solutions arena consist of ownership in ScoutCam (OTCQB: SCTC), Inc, and Polyzion, LTD. The Company\u2019s affiliates in digital commerce include Gix Internet Ltd. (TASE:GIX), Jeff&#8217;s Brands and Eventer Technologies, Ltd. In the electric vehicle market, Charging Robotics, Ltd. and Revolz are also part of the Company\u2019s portfolio of technology solution providers. Medigus is traded on the Nasdaq Capital Market. To learn more about Medigus\u2019 advanced technologies, please visit\u00a0<u>http:\/\/www.medigus.com\/investor-relations.<\/u><\/p>\n<p>\n        <b>Cautionary Note Regarding\u00a0Forward Looking Statements<\/b>\n      <\/p>\n<p align=\"justify\">This press release may contain statements that are \u201cForward-Looking Statements,\u201d which are based upon the current estimates, assumptions and expectations of Medigus\u2019 management and its knowledge of the relevant market. The company has tried, where possible, to identify such information and statements by using words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201cenvision,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201ctarget,\u201d \u201cpotential,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201ccontinue,\u201d \u201ccontemplate\u201d and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words. For example, Medigus uses forward looking statements when describing conclusions from Polyrizon\u2019s\u00a0pre-clinical study, the potential of Polyrizon\u2019s product candidate on the viral load and the immune system and the product candidate\u2019s preventative effect. These forward-looking statements represent Medigus\u2019 expectations or beliefs concerning future events, and it is possible that the results described in this press release will not be achieved. By their nature, Forward-Looking Statements involve known and unknown risks, uncertainties and other factors which may cause future results of the Medigus\u2019 activity to differ significantly from the content and implications of such statements. Other risk factors affecting Medigus and\u00a0Polyrizon\u00a0are discussed in detail in the Medigus\u2019 filings with the Securities and Exchange Commission. Forward-Looking Statements are pertinent only as of the date on which they are made, and Medigus undertakes no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, future developments or otherwise. Neither Medigus nor its shareholders, officers and employees, shall be liable for any action and the results of any action taken by any person based on the information contained herein, including without limitation the purchase or sale of Medigus\u2019 securities. Nothing in this press release should be deemed to be medical or other advice of any kind.\u00a0<\/p>\n<p>\n        <b>Contact (for media only)<\/b>\n      <\/p>\n<p>Tali Dinar<\/p>\n<p>Chief Financial Officer<\/p>\n<p>+972-8-6466-880<\/p>\n<p>ir@medigus.com <\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/M2QzZGQxOTUtODAxNi00NDE2LWIwNmItYjYzOTcyOTBjM2I1LTUwMDA2NDMzMQ==\/tiny\/Medigus-Ltd.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In recent pre- clinical studies, Polyrizon products showed strong potential by preventing coronavirus and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells&#8217; death. OMER, Israel, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, has submitted an additional patent application to the United States Patent and Trademark Office for its innovative technology. The invention generally pertains to the field of hydrogels that are capable to capture and contain biological assaults intrusion through the upper airways and eye cavities. Furthermore, the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533707","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"In recent pre- clinical studies, Polyrizon products showed strong potential by preventing coronavirus and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells&#8217; death. OMER, Israel, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, has submitted an additional patent application to the United States Patent and Trademark Office for its innovative technology. The invention generally pertains to the field of hydrogels that are capable to capture and contain biological assaults intrusion through the upper airways and eye cavities. Furthermore, the &hellip; Continue reading &quot;Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T11:34:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue\",\"datePublished\":\"2021-09-02T11:34:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/\"},\"wordCount\":725,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/\",\"name\":\"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==\",\"datePublished\":\"2021-09-02T11:34:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/","og_locale":"en_US","og_type":"article","og_title":"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue - Market Newsdesk","og_description":"In recent pre- clinical studies, Polyrizon products showed strong potential by preventing coronavirus and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells&#8217; death. OMER, Israel, Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced that Polyrizon Ltd., a privately held company which Medigus owns 35.86% of its share capital, has submitted an additional patent application to the United States Patent and Trademark Office for its innovative technology. The invention generally pertains to the field of hydrogels that are capable to capture and contain biological assaults intrusion through the upper airways and eye cavities. Furthermore, the &hellip; Continue reading \"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T11:34:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue","datePublished":"2021-09-02T11:34:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/"},"wordCount":725,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/","name":"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==","datePublished":"2021-09-02T11:34:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxOTQ2MyM0Mzg2OTE3IzUwMDA2NDMzMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medigus-polyrizon-submits-a-patent-application-for-prevention-of-pathogens-such-as-coronavirus-and-allergens-from-affecting-nasal-tissue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533707"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533707\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}